ENTA  valuation analysis

Basics
Name: Enanta Pharmaceuticals, Inc
Description: Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 06, 2021
Market cap: $952.53M (753rd)
Sales(TTM): $94.16M (823rd)
Earnings(TTM): -$73.98M (726th)

Value
FFER: 1.25 (why)
Actual price: $47.19
FFEThis is Enanta Pharmaceuticals, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $39.06
Quantile: ENTA is expensive given its fundamentals.
Prices as of EOD 2021-06-16
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Enanta Pharmaceuticals, Inc's earnings decreased from $23.66M to -$73.98M in the last year.
  • Enanta Pharmaceuticals, Inc's operating income decreased from $11.18M to -$84.63M in the last year.
Earnings / MarketCap
Enanta Pharmaceuticals, Inc
"Biotechnology" industry
Sales / MarketCap
Enanta Pharmaceuticals, Inc
"Biotechnology" industry
Book / MarketCap
Enanta Pharmaceuticals, Inc
"Biotechnology" industry
Equity / Assets
Enanta Pharmaceuticals, Inc
"Biotechnology" industry